Expansion Plans for 2018–2020

Established in 2010, Asian commenced with a 350-bed facility at Faridabad with centers of excellence across key tertiary care specialties including cardiology, oncology, nephrology, critical care, and orthopedics. The company raised series of private equities from Orbimed in 2014 and has further expanded the business with four more hospitals at Dhanbad, Moradabad, Sambhal, Yamuna Vihar, and three primary healthcare clinics in and around Faridabad over the last 3 years. As part of the next phase of expansion, the Group intends to add 1000 more beds over the next 3 years with new hospitals being planned across states of Delhi NCR, Haryana, UP, Bihar, and Jharkhand.

Asian Faridabad is one of the hospitals to get NABH accreditation at the earliest and has several accolades to its credit including being rated as one of the top five facilities in Delhi, NCR by The Week (2017), the Best Healthcare Brand in India by ET in 2017, and was also rated in the top 10 hospitals by All India Lifestyle Hospital and Clinic Survey by TOI in 2015 and 2016.

CDC, the UK’s development finance institution, a leading investor operating in growth markets, is investing in Asian Institute of Medical Sciences. This investment will let us expand and develop high-quality medical facilities, allowing us to replicate our success at Faridabad across the other major towns in UP, Bihar, and Jharkhand. The current investment would give us the capacity to expand the number of beds available to patients from the current level of 700+ to close to 1750 by 2021.

Asian firmly believes in quality healthcare which is a basic need and needs to be delivered closer to where the need is and not only in big metros. The social impact focused investment approach taken by CDC and the ability to stay invested for a longer tenor help us achieve our vision of reaching out to those Tier II and Tier III towns of North and East India that have a huge unmet demand of quality healthcare services.